期刊文献+

uPA基因缺失型小鼠与野生型小鼠肝纤维化模型的比较研究 被引量:4

Comparative study on Liver Fibrosis Models Using uPA Knock-out Mice and Wild-type Mice
下载PDF
导出
摘要 目的分别采用C57BL/6J野生型(wT)和uPA基因缺失(uPA-/-)小鼠构建肝纤维化动物模型,并进行比较研究。方法选取成年雄性C57BL/6J野生型和uPA-/-小鼠,分为4组:对照组(WT,uPA-/-)和模型组(WT,uPA-/-),每组10只。模型组小鼠腹腔注射10%CCl40.15ml,对照组小鼠腹腔注射橄榄油0.15ml,每周2次,连续4周和6周。测定动物血清中ALT、AST、ALB及A/G等生化指标;盐酸水解法测定肝组织羟脯氨酸(Hyp);用放射免疫法测定血清Ⅲ型前胶原蛋白(PCⅢ)含量;用HE染色及Masson三色胶原染色观察肝组织病理学改变。结果造模4周和6周时,无论是wT模型组小鼠还是uPA-/-模型组小鼠血清ALT和AST活性均较对照组小鼠显著升高,ALB含量降低(P〈0.01);造模4周时,仅见uPA-/-小鼠的A/G含量降低(P〈0.01)。造模4周和6周时,uPA-/-模型组小鼠血清PCⅢ水平和肝脏组织Hyp含量较对照组显著升高(P〈0.01);造模6周时,wT模型组小鼠才出现血清PCⅢ水平和肝脏组织Hyp含量升高(P〈0.01),且升高值明显低于uPA-/-模型组小鼠。病理组织学观察显示,uPA-/-模型组的肝脏纤维化程度比wT模型组明显严重。结论与WT小鼠相比,采用uPA-/-小鼠建立肝纤维化动物模型的造模周期明显缩短,肝纤维化程度更严重。 Objective To build and compare two liver fibrosis models using uPA knock-out (uPA-/-) mice and wild-type (WT) mice. Methods Adult male C57BL/6J WT mice and uPA knock-out (uPA-/ -) mice were divided into four groups with 10 mice in each group: control groups (WT, uPA-/-) and liver fibrosis model groups (WT, uPA-/-). Mice were injected intraperitoneally with 0.15ml 10% CCh (or olive oil as control) 2 times per week for 4 weeks and 6 weeks respectively. Serum alanine aminotransferase (ALT), aspartate(AST), albumin(ALB) and albumin/globulin(A/G) were determined, liver hydroxyproline (Hyp) level was determined using hydrochloric acid hydrolysis method and serum procollagen III (PC III) content was measured by radioimmunoassay; liver histopathology were performed using HE staining and Masson staining. Results After modeling for 4 weeks and 6 weeks, serum ALT and AST activity of both WT mice and uPA-/- mice significantly increased while serum Alb content significantly decreased comparing with control (P〈0.01); at 4 weeks, significant decrease of A/G content was found in uPA-/- mice model only (P〈0.01). After modeling for 4 weeks and 6 weeks, serum PC III level and liver Hyp content of uPA-/- mice model significantly increased comparing with control (P〈0.01); At 6 weeks, serum PC III level and liver Hyp content of WT mice models started to increase significantly (P〈0.01), and the elevated values were not as high as those in uPA-/- mice model. Histopathology showed that the degree of liver fibrosis in uPA-/- mice model was more severe than that in WT mice model. Conclusion Compared with C57BL/6J WT mice, establishment of liver fibrosis model by using uPA-/- mice was required shorter time and showed more severe degree of liver fibrosis.
出处 《实验动物与比较医学》 CAS 2011年第4期231-235,共5页 Laboratory Animal and Comparative Medicine
基金 上海市科委基金项目(09140902800)
关键词 uPA基因缺失小鼠 CCL4 肝纤维化 动物模型 uPA knock-out mice CC14 Liver fibrosis Animal model
  • 相关文献

参考文献8

  • 1Bataller R,Brenner DA.Liver fibrosis[J].J Clin Invest,2005,115(2):209-218.
  • 2Monto A,Patel K,Bostrom A,Pianko S,et al.Risks of a range of alcohol intake on hepatitis C-related fibrosis[J].Hepatology,2004,39(3):826-834.
  • 3Okazaki I,Watanabe T,Hozawa S,et al.Molecular mechanism of the reversibility of hepatic fibrosis:with special reference to the role of matrix metalloproteinases[J].J Gastroenterol Hepatol,2000,15 Suppl:D26-32.
  • 4Watanabe T,Niioka M,Ishikawa A,etal.Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat[J].J Hepatol,2001,35(4):465-473.
  • 5Salgado S,Garcia J,Vera J,et al.Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy[J].Mol Ther.2000,2(6):545-51.
  • 6Kim TH,Mars WM,Stolz DB,et al.Extracellular matrix remodeling at the early stages of liver regeneration in the rat[J].Hepatology,1997,26(4):896-904.
  • 7Ling C,Zou T,Hsio Y,et al.Disruption of tissue plasminogen activator gene reduces macrophage migration[J].Biochem Biophys Res Commun,2006,349(3):906-912.
  • 8Bueno M,Salgado S,Beas-Zárate C,et al.Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs,HGF and VEGF[J].J Gene Medicine,2006,8(11):1291-1299.

同被引文献53

  • 1Friedman SL. Mechanisms of hepatic fibrogenesis[J].Gastroenterology, 2008,134:1655-1669.
  • 2Schuppan D,Ruehl M,Somasundaram R, et al Matrix as amodulator of hepatic fibrogenesis [J]. Semin Liver Dis, 2001,21:351-372.
  • 3Somerville RP, Oblander SA, Apte SS. Matrix metallo-proteinases: old dogs with new tricks [J]. Genome Biol, 2003,4:216-222.
  • 4Iredale JP. Tissue inhibitors of metalloproteinases in liverfibrosis [J]. Int J Biochem Cell Biol ,1997,29:43-54.
  • 5Carpino G, Morini S, Ginanni Corradini S,et al. Alpha-SMAexpression in hepatic stellate cells and quantitative analysisof hepatic fibrosis in cirrhosis and in recurrent chronic hepa-titis after liver transplantation [J]. Dig Liver Dis, 2005,37:349-356.
  • 6Murphy G,Atkinson S, Ward R, et al. The role of plasminogenactivators in the regulation of connective tissuemetakkoproteinases [J]. Ann N Y Acad Sci, 1992,667:1-12.
  • 7Iredale JP. Models of liver fibrosis: exploring the dynamicnature of inflammation and repair in a solid organ [J]. J ClinInvest, 2007, 117:539-548.
  • 8Tsukamoto H,Matsuoka M, French SW. Experimental modelsof hepatic fibrosis: a review [J]. Semin Liver Dis, 1990, 10:56-65.
  • 9Bumand KG, Gaffney PJ, McGuinness CL, et al. The role ofthe monocyte in the generation and dissolution of arterial andvenous thrombi [J]. Cardiovasc Surg ,1998, 6:119-125.
  • 10Swaisgood CM, French EL, Noga C,et al. The developmentof blemycin-induced pulmonary fibrosis in mice deficientfor components of the fibrinolytic system [J]. Am J Pathol,2000,157:177-187.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部